🧬 The U.S. has officially approved the use of the innovative drug Lenacapavir (Yeztugo) for HIV prevention. It is the world’s first PrEP (pre-exposure prophylaxis) medication that provides nearly 100% protection.
Source: Pryamyi
🛡️ The drug blocks the virus from entering human cells and is administered only twice a year as an injection. This makes it especially convenient for people with limited access to healthcare or those facing stigma.
📉 In large-scale clinical trials, the drug demonstrated extremely high effectiveness with minimal side effects. It outperforms similar medications that require daily or frequent use.
💰 The drug costs over $40,000 per year, which has drawn criticism from experts. Estimates suggest that its actual production cost could be a thousand times lower.
🌍 In Europe, Lenacapavir is currently approved only for HIV treatment, not prevention. However, with U.S. approval, the path to commercial rollout is now open.